SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

MALAGA, Germán et al. Vasculitis secundaria a infección por Fasciola hepática. Rev Peru Med Exp Salud Publica [online]. 2012, vol.29, n.3, pp. 386-389. ISSN 1726-4634.  http://dx.doi.org/10.1590/S1726-46342012000300015.

    1. Keiser J, Utzinger J. Emerging foodborne trematodiasis. Emerg Infect Dis. 2005;11(10):1507-14. [ Links ]

    2. Marcos L, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, et al. High prevalence rates of human fascioliasis in Peru: an emerging disease. Rev Per Enf Infec Trop. 2005;3:8-13. [ Links ]

    3. Marcos L, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. 2008; 21:523530. [ Links ]

    4. Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, et al. Natural history, clinico-radiologic correlates and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg. 2008;78(2):222-7. [ Links ]

    5. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria of the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33(8):1088-93. [ Links ]

    6. Gonzlez-Gay MA, Garca-Porra C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27(4):729-49. [ Links ]

    7. Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol. 2006;24(2 Suppl 41):S71-81 [ Links ]

    8. Ticse R, Varela L, Berrocal K, Gotuzzo E, Delgado S. Sndrome de crioglobulinemia mixta secundario a brucelosis. Reporte de un caso. Rev Med Hered. 2007;18(1):34-8 [ Links ]

    9. Llanos C, Soto L, Sabug F, Gallegos I, Valenzuela O, Verdaguer J, et al. Systemic vasculitis associated with Fasciola hepatica infection. Scand J Rheumatol. 2006;35(2):143-6 [ Links ]

    10. Oujamaa L, Sibon I, Vital A, Menegon P. Vasculite crbrale secondaire une co-infestation par Toxocara canis et Fasciola hepatica. Rev Neurol (Paris). 2003;159(4):447-50. [ Links ]

    11. El-Tantawy WH, Salem HF, Mohammed Safwat NA. Effect of fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects. Pharm World Sci. 2007;29(3):190-8. [ Links ]

    12. Marcos LA, Yi P, Machicado A, Andrade R, Samalvides F, Snchez J, et al. Hepatic fibrosis and Fasciola hepatica infection in cattle. J Helminthol. 2007;81(4):381-6. [ Links ]

    13. Alban M, Jave J, Quispe T. Fasciolasis en Cajamarca. Rev gastroenterol Per. 2002;22(1):28-32. [ Links ]

    14. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2002;46(12):3317-26. [ Links ]